Market Cap (In CAD)
24.66 Million
Revenue (In CAD)
33.06 Million
Net Income (In CAD)
-13.08 Million
Avg. Volume
151.72 Thousand
- Currency
- CAD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.06-0.1
- PE
- -
- EPS
- -
- Beta Value
- 0.921
- ISIN
- CA58504D1006
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. David A. Pidduck
- Employee Count
- -
- Website
- https://www.medipharmlabs.com
- Ipo Date
- 2019-03-04
- Details
- MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada, Australia, Germany, and internationally. It formulates, processes, packages, and distributes cannabis extracts and advanced cannabinoid-based products. The company also provides GMP flower sourcing, packaging, and distribution services. MediPharm Labs Corp. was founded in 2015 and is headquartered in Barrie, Canada.
More Stocks
-
TBEV
-
MVP
-
002824
-
GEM
-
CDBDFCloudbreak Discovery Plc
CDBDF
-
UPPR
-
TANATana Resources Corp.
TANA
-
600211